Parkinson Platform Noord Nederland

For most medications, positive findings from large randomised controlled trials herald regulatory approval and subsequent marketing. Not so for apomorphine infusion, which arrived two decades ago as a treatment for Parkinson's disease, following publication of a relatively small open-label study.1 Previously used as an emetic, an opiate addiction remedy, an aphrodisiac, and even as a plot element for an Agatha Christie tale,2 subcutaneous apomorphine infusion eventually became widely used for the treatment of Parkinson's disease.